Kynexis extends its Series A funding by €40 million, bringing the total to €97 million. The funding, led by Novartis Venture Fund, will support Phase 2 studies for its cognitive medicine.
Amount Raised
€40 Million
Round Type
Series A
North HollandBiotechnologyHealth CareTherapeuticsInvestors
Description
Kynexis announced the closing of a €40 million Series A extension, increasing total Series A financing to €97 million. The financing was led by Novartis Venture Fund, with participation from existing investors. It will support close-out activities for a Phase 2 study of KYN-5356 for cognitive impairment. The company is also preparing for registrational studies and aims to advance towards additional cognitive disorders.
Quick answer
Kynexis raised €40 Million in a Series A round, dated August 19, 2026. Investors: Sunstone Life Science Ventures, Forbion, Ysios Capital and Novartis Venture Fund. Kynexis is based in North Holland, Netherlands.
- How much did Kynexis raise?
- Kynexis raised €40 Million in a Series A round on August 19, 2026.
- Who invested in Kynexis?
- Sunstone Life Science Ventures, Forbion, Ysios Capital and Novartis Venture Fund are named as investors in this round.
- What does Kynexis do?
- Kynexis is a clinical-stage biotechnology company focused on improving cognition for people living with brain diseases.
- Where is Kynexis based and how big is it?
- Kynexis is based in North Holland, Netherlands. Fundz records about 21 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Kynexis that raised within 45 days of this round, from Fundz verified event records.
- Ensho Therapeutics raised $7.3M on October 2, 2026.
- Omnio raised $3.3M (Seed) on October 2, 2026.
- R1 Therapeutics raised $81M (Series A) on September 30, 2026.
- Breye Therapeutics raised $77M (Series A) on September 29, 2026.
- Aptadir Therapeutics raised $45M (Seed) on September 29, 2026.
- Link Cell Therapies raised $30M (Series A) on September 28, 2026.
Who to call at Kynexis, and when
A new round usually means Kynexis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kynexis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kynexis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kynexis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kynexis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansKynexis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.